Borealis Biosciences
PrivateLast Round
Series A
Extension
Dec 19, 2024
Total Funding Raised
$210M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Borealis Biosciences operates in Healthcare & Life Sciences and is based in Vancouver. Its latest recorded funding round was a Series A Extension round in December 2024.
Borealis Biosciences is a biotechnology company that develops next-generation xRNA-based medicines for kidney diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Borealis Biosciences Comparables
Compare Borealis Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Judo Bio | 84% | |
| Purespring Therapeutics | 83% | |
| Zeal Therapeutics, Inc. | 82% |
For institutional investors. Book with your work email.
Borealis Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Dec 19, 2024 | ||||
| Series A | Aug 22, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Borealis Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Westlake Village BioPartners | Series A, Series A Extension |
| Versant Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 35% to 2.2K.
- Aug 22, 2024
$180M round led by Novartis and Westlake Village BioPartners.
For institutional investors. Book with your work email.
Borealis Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Borealis Biosciences's valuation, stock price, and market status.
Is Borealis Biosciences a public or private company?
Borealis Biosciences is a private company.
What is the current stock price of Borealis Biosciences?
Borealis Biosciences is a private company, so its shares have no public market price. Caplight tracks Borealis Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Borealis Biosciences worth (valuation)?
Valuation information for Borealis Biosciences is not publicly available.
Can I buy Borealis Biosciences stock?
Borealis Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Borealis Biosciences's last funding round?
Borealis Biosciences's most recent funding round was Series A Extension on December 19, 2024.
Who are the main investors in Borealis Biosciences?
Key investors in Borealis Biosciences include Westlake Village BioPartners.
Will Borealis Biosciences IPO soon?
No public IPO plans have been announced for Borealis Biosciences.
How can I track Borealis Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Borealis Biosciences's shares on secondary markets.